Label: RAYDERM HYDRATING TONER- glycerin toner liquid
-
Contains inactivated NDC Code(s)
NDC Code(s): 72543-004-01 - Packager: VORY MEDICAL. Inc
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated October 11, 2018
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT
-
INACTIVE INGREDIENT
Purified Water, Propanediol, Dipropylene, Methyl Gluceth-20, Glycereth-26, Glycerin, Pentylene Glycol, Betaine, C12-14 Pareth-12, Trehalose, Salvia Hispanica Seed Extract, Centella Asiatica Extract, Houttuynia Cordata Extract, Polyquaternium-51, Sodium Citrate, Sea Buckthorn Water, Butylene Glycol, Ethylhexylglycerin, 1,2-Hexanediol, Citric Acid, Sodium Palmitoyl Proline, Nymphaea Tetragona Flower Extract, Green tea Extract, Black Rice Bran Extract, Cucumber Extract, Caprylyl Glycol, Fragrance
- PURPOSE
-
WARNINGS
Precautions of Use
1) If rash, redness, swelling, itching or other adverse reactions occur as a result of exposure to sunlight during or after use, consult a doctor / specialist.
2) Refrain from using on wound sites.
3) Storage and handling precautions:
i) Keep out of reach of children.
ii) Keep away from direct sunlight - KEEP OUT OF REACH OF CHILDREN
- INDICATIONS & USAGE
- DOSAGE & ADMINISTRATION
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
RAYDERM HYDRATING TONER
glycerin toner liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:72543-004 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength glycerin (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) glycerin 6.25 g in 250 mL Inactive Ingredients Ingredient Name Strength water (UNII: 059QF0KO0R) PROPANEDIOL (UNII: 5965N8W85T) DIPROPYLENE GLYCOL (UNII: E107L85C40) METHYL GLUCETH-20 (UNII: J3QD0LD11P) GLYCERETH-26 (UNII: NNE56F2N14) PENTYLENE GLYCOL (UNII: 50C1307PZG) BETAINE (UNII: 3SCV180C9W) C12-14 PARETH-12 (UNII: M0LJS773XW) TREHALOSE (UNII: B8WCK70T7I) SALVIA HISPANICA SEED (UNII: NU0OLX06F8) CENTELLA ASIATICA (UNII: 7M867G6T1U) POLYQUATERNIUM-51 (2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE/N-BUTYL METHACRYLATE; 3:7) (UNII: EL9825H96J) SODIUM CITRATE (UNII: 1Q73Q2JULR) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) ETHYLHEXYLGLYCERIN (UNII: 147D247K3P) 1,2-HEXANEDIOL (UNII: TR046Y3K1G) SODIUM PALMITOYL PROLINE (UNII: 64L053FRFO) NYMPHAEA ALBA FLOWER (UNII: 40KQ7Q535O) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72543-004-01 250 mL in 1 PACKAGE; Type 0: Not a Combination Product 10/11/2018 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 10/11/2018 Labeler - VORY MEDICAL. Inc (694721104) Registrant - VORY MEDICAL. Inc (694721104) Establishment Name Address ID/FEI Business Operations VORY MEDICAL. Inc 694721104 manufacture(72543-004)